Some clouds. Low around 60F. Winds light and variable..
Some clouds. Low around 60F. Winds light and variable.
Updated: August 29, 2026 @ 8:10 pm
Federal courts are confronting allegations that major MSOs marketed recreational cannabis as medicine without FDA clinical trials, while MMJ’s cases challenge a system that penalized the company that followed the federal drug-development pathway.
WASHINGTON, D.C. / ACCESS Newswire / August 25, 2026 / MMJ International Holdings today called attention to a rapidly developing collision between federal marijuana policy, unsupported medical marketing allegations and insurance coverage that could have consequences across the cannabis industry.
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Story continues below video
Copyright 2026 ACCESS Newswire. All Rights Reserved.
Your comment has been submitted.
Reported
There was a problem reporting this.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.
Sign up now to get our FREE breaking news coverage delivered right to your inbox.
First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the people peaceably to assemble, and to petition the Government for a redress of grievances.
Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers: